Cronos Group Inc (CRON)
NASDAQ • Healthcare
January 21, 2026 at 21:00 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Cronos Group Inc is a cannabis company that approaches the category as a science-led, compliance-first business. Production is planned around controlled grow conditions, standardized processing, and documentation that clears regulatory review across jurisdictions. Adult-use products are designed for licensed retail with clear communication on potency and storage; medical formats are produced for physician-directed channels with a focus on predictable release profiles. Rather than flooding the market, Cronos advances lines in measured steps and retires what does not fit routine use or labeling rules. Export activity is staged with local partners and agencies so logistics, testing, and age controls are aligned before scale is added. Within consumer staples and healthcare, the company presents cannabis as a regulated product class that must be earned lot by lot through method, transparency, and steady stewardship.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Cronos Group Inc's Technical Indicators Summary
CRON’s technical outlook remains neutral as the stock trades just below its short- and medium-term moving averages, which predominantly signal selling pressure, while the longer-term 200-day averages suggest some underlying support. Momentum indicators present a mixed picture: the RSI near 39 and the MACD slightly negative point to weak downward momentum, whereas oversold readings in the stochastic and Williams %R hint at potential buying interest. The ADX indicates a lack of strong trend strength, and volatility measured by the ATR is moderate, reflecting stable price fluctuations. Meanwhile, volume trends on the OBV lean toward selling. Overall, CRON shows balanced forces with no clear directional bias at this time.
| Indicator | Value |
|---|---|
RSI (14) | 38.74 |
Stochastic %K (14, 3, 3) | 6.52 |
CCI (20) | -141.24 |
WPR (14) | -100.00 |
Momentum (10) | -0.17 |
MFI | 33.05 |
MACD Level (12, 26) | -0.02 |
Bollinger Bands | $2.49 - $2.91 |
ATR (14) | $0.11 (4.47%) |
ADX (14) | 20.30 |
OBV | 44,211,300 |
Simple Moving Averages | $2.31 - $2.70(5 indicators) |
Exponential Moving Averages | $2.33 - $2.67(5 indicators) |
Get premium market insights delivered directly to your inbox.
Buying out of the gate leaves CRON 2.353% above yesterday’s close, trading at 2.61. The sector shows a modest gain of 1.05%, offering a gentle tailwind. CRON opens higher amid a modest sector gain, with no recent news directly impacting the stock.
Price Change
from $2.55 close
+$0.06
Trading Volume
Below avg (1.3M)
778.6K
vs S&P 500 Today
Moderate Underperformance
-0.13%
52-Week Position
Mid-range
55.2%
Updated: January 21, 2026 at 17:32 UTC